ACT CAPITAL MANAGEMENT, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1442273 WAYNE, PA

Position in ARWR

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$5,172,750

+$193,500 QoQ

Shares Held

82,500

+10.0% QoQ

Ownership

0.059%

of shares outstanding

% of Portfolio

4.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ACT CAPITAL MANAGEMENT, LLC holds $76,499,907 across 26 Biotechnology names. ARWR ranks #6 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	60,477	$15,622,418
2	CELC	Celcuity Inc.	91,675	$10,463,784
3	TGTX	Tg Therapeutics, Inc.	249,025	$8,272,610
4	ABVX	Abivax S.A.	70,900	$7,894,715
5	VKTX	Viking Therapeutics, Inc.	209,300	$6,810,622
6	ARWR	Arrowhead Pharmaceuticals, Inc. This page	82,500	$5,172,750
7	NKTR	Nektar Therapeutics	70,900	$5,101,255
8	CYTK	Cytokinetics Inc	64,500	$4,251,195

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,172,750	82,500	+10.0%	Shares	Sole	2026-05-08
2025-12-31	$4,979,250	75,000	-32.1%	Shares	Sole	2026-02-17
2022-09-30	$3,652,025	110,500	-18.1%	Shares	Sole	2022-11-03
2022-06-30	$4,753,350	135,000	-32.8%	Shares	Sole	2022-08-12
2022-03-31	$9,243,990	201,000	-4.5%	Shares	Sole	2022-05-11
2021-12-31	$13,956,150	210,500	+8.5%	Shares	Sole	2022-02-03
2021-09-30	$12,111,420	194,000	-7.0%	Shares	Sole	2021-11-16
2021-06-30	$17,276,252	208,600	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.